During the past few years, progress has been made in developing high throughput technologies for protein cloning, expression, purification, crystallization, crystal imaging, and synchrotron beamline data collection. Recently, we have been able to miniaturize and parrallelize the structural biology processes significantly using nanoliter volume technologies. Accordingly, significantly smaller amounts of materials can be used at all steps, and more parallel experiments can be engineered (genetic and mechanical) within the same space and time constraints. A description of these technology developments and the current status of throughput will be described. Applications of the technologies towards genomes, pathways, and drug discovery will be included.
The RIKEN Institute has started the Structural Genomics/Proteomics Initiative (RSGI) (http://www.rsgi.riken.go.jp) at the Genomic Sciences Center (GSC) in Yokohama and the Harima Institute at SPring-8. We are determining the threedimensional structures of proteins of new sequence families and analyzing molecular and cellular functions of these proteins in order to establish the structure-function relationships.
Efficient approaches in related key technologies have made possible to conduct the research in a high-throughput way. Cell-free protein expression is highly suitable for making protein samples. The system may produce proteins directly from PCR-amplified linear DNA fragments, requiring no cloning procedures. Hundreds of proteins and protein domains can be expressed from cDNA clones within a day. By establishing the dialysis method, production of proteins has been further improved to the level of milligram quantities. The system is useful to assess the solubility and structural stability of proteins and thus practical for selecting protein samples for larger scale production. In addition, it is successful in preparing labeled protein samples, the uniformly [13C, 15N]-labeled proteins for NMR structure determination and selenomethionine substituted proteins for X-ray crystallography. The robotic system has been adapted to advance the automated protein production. The system accelerates high-throughput structure determinations by both X-ray crystallography and NMR spectroscopy. The NMR facility of GSC has 16 NMR instruments (600 and 800 MHz). High-throughput Factory directed by M. Miyano has been newly established and two beam lines dedicated to structural genomics are being constructed at SPring-8 in Harima.
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